MeVis Medical Solutions AG (ETR:M3V)

ETR:M3V Ratios and Metrics

Market cap in millions EUR. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 8, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	42	45	42	52	62	59
Market Cap Growth	-11.45%	7.83%	-19.01%	-16.96%	4.91%	2.52%
Enterprise Value	36	43	37	47	58	55
Last Close Price	23.20	23.90	21.37	25.36	29.72	27.51
PE Ratio	13.34	14.26	9.18	10.51	7.99	13.05
Forward PE	-	16.98	16.98	16.98	16.98	16.98
PS Ratio	2.63	2.81	2.47	2.98	3.32	3.66
PB Ratio	2.37	2.53	2.35	2.90	3.49	3.33
P/TBV Ratio	2.37	2.53	2.35	2.90	3.49	3.33
P/FCF Ratio	11.29	12.07	14.72	8.95	13.18	6.53
P/OCF Ratio	10.89	11.64	13.30	8.83	12.81	6.50
EV/Sales Ratio	2.22	2.65	2.18	2.73	3.09	3.41
EV/EBITDA Ratio	14.47	17.26	8.95	9.53	8.83	10.75
EV/EBIT Ratio	15.39	18.35	9.24	9.72	8.96	11.02
EV/FCF Ratio	9.55	11.39	13.00	8.19	12.26	6.09
Net Debt / Equity Ratio	-0.37	-0.37	-0.37	-0.43	-0.52	-0.43
Net Debt / EBITDA Ratio	-2.64	-2.64	-1.58	-1.56	-1.42	-1.48
Net Debt / FCF Ratio	-1.74	-1.74	-2.29	-1.34	-1.97	-0.84
Asset Turnover	0.61	0.61	0.62	0.59	0.64	0.59
Quick Ratio	4.13	4.13	4.14	3.99	4.68	4.41
Current Ratio	4.24	4.24	4.26	4.10	4.78	4.56
Return on Equity (ROE)	17.76%	17.76%	25.59%	27.60%	43.70%	25.50%
Return on Assets (ROA)	5.54%	5.54%	9.17%	10.26%	13.76%	11.33%
Return on Invested Capital (ROIC)	19.82%	19.82%	36.43%	51.15%	68.35%	40.90%
Return on Capital Employed (ROCE)	9.80%	9.80%	16.50%	19.20%	22.90%	19.90%
Earnings Yield	7.50%	7.01%	10.90%	9.52%	12.51%	7.66%
FCF Yield	8.85%	8.28%	6.79%	11.17%	7.59%	15.30%
Dividend Yield	4.87%	4.73%	5.29%	3.75%	-	-
Total Shareholder Return	4.87%	4.73%	5.29%	3.75%	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.